Severity of Ischemic Stroke After Left Atrial Appendage Closure vs Nonwarfarin Oral Anticoagulants
-
Published:2023-11
Issue:
Volume:
Page:
-
ISSN:2405-500X
-
Container-title:JACC: Clinical Electrophysiology
-
language:en
-
Short-container-title:JACC: Clinical Electrophysiology
Author:
Turagam Mohit K., Kawamura Iwanari, Neuzil Petr, Nair Devi, Doshi Shephal, Valderrabano Miguel, Hala Pavel, Della Rocca DomenicoORCID, Gibson Douglas, Funasako Moritoshi, Ha Grace, Lee BridgetORCID, Musikantow Daniel, Yoo David, Flautt Thomas, Dukkipati Srinivas, Natale AndreaORCID, Gurol Mahmut E., Halperin Jonathan, Mansour Moussa, Reddy Vivek Y.
Reference33 articles.
1. Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study);Zoni-Berisso;Am J Cardiol,2013 2. Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated?;Miller;Stroke,2005 3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014 4. Antithrombotic treatment at onset of stroke with atrial fibrillation, functional outcome, and fatality: a systematic review and meta-analysis;Hannon;Int J Stroke,2015 5. Admission severity of atrial-fibrillation-related acute ischemic stroke in patients under anticoagulation treatment: a systematic review and meta-analysis;Garcia;J Clin Med,2022
|
|